Listen to TB science

October 2012
Mail on Sunday;10/28/2012, p101
Badger culling is ineffective in combating bovine TB, as outlined by Brian May in your paper. Only an obdurate or foolish person could ignore the evidence of scientists and the fact that European politicians are prepared to accept products from vaccinated cattle.


Related Articles

  • Like a song, get your tune stuck in their head. Gitomer, Jeffrey // Business Journal (Central New York);9/13/2002, Vol. 16 Issue 37, p10 

    Presents guidelines on the science of listening. Pleasure of listening; Importance of music in getting others listen; Addition of production quality to words.

  • Are You Really Listening to Your Customers? Colombo, George // Business Credit;Jun2004, Vol. 106 Issue 6, p66 

    Offers tips for entrepreneurs on how to listen to their customers. Importance of listening to customers; Science and art of listening; Definition of purposeful, active and capturing types of listening; Aggregation of captured information; Analysis of the aggregated information.

  • Summary of the evidence base for controlling bovine TB.  // Veterinary Record: Journal of the British Veterinary Association;8/31/2013, Vol. 173 Issue 8, p175 

    The article informs about a paper related to the succinct summary of the natural science evidence base relevant to the control of bovine tuberculosis (TB).

  • Progress in Materials Science (Book). Schultz, Jerold M. // American Scientist;Mar/Apr84, Vol. 72 Issue 2, p215 

    Reviews the book 'Progress in Materials Science,' edited by J.W. Christian, P. Haasen and T.B. Massalski.

  • TB vaccination trial in the spotlight. Tasker, Johann // Farmers Weekly;4/16/2010, Vol. 152 Issue 15, p10 

    The article focuses on the Bovine Tuberculosis (TB) Badger Vaccine Deployment Project (BVDP), a badger vaccine trial aimed at fighting bovine TB in Great Britain which will be accompanied by a social science study to evaluate the level of farmer confidence in the use of the bovine TB badger vaccine.

  • 'Novel Curefor TB'. VENKATESH, AISHWARYA // BioSpectrum;Sep2014, Vol. 12 Issue 9, p48 

    An interview with professor V. Nagaraja of the Department of Cell Biology and Microbiology at the Indian Institute of Science (IISc) is presented. Topics discussed by Nagaraja include the evolution and spread of the multidrug resistance strain of tuberculosis (TB) in the population, the...

  • Q & A.  // Daily Mail;3/28/2014, p4 


  • Q & A.  // Daily Mail;3/28/2014, p4 


  • Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps. Amaral, L.; Matins, M.; Viveiros, M.; Molnar, J.; Kristiansen, J. E. // Current Drug Targets;Sep2008, Vol. 9 Issue 9, p816 

    Global rates of pulmonary tuberculosis (TB) continue to increase. Moreover, resistance of the causative organism Mycobacterium tuberculosis to the two most effective anti-TB medications continue to rise. Now, multi-drug resistant TB (MDR-TB) has progressed to extensively drug resistant TB...

  • Take the NSTA Reports Poll: Do Your Science Students Argue From Evidence?  // NSTA Express;3/24/2014, p6 

    The article discusses the use of science students of argumentation to listen to, compare and evaluate competing ideas and methods based on merits from the Next Generation Science Standards.


Read the Article

Other Topics